Published in Neuropsychologia on January 01, 2004
Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex (2010) 3.13
Preoperative and postoperative neurological, neuropsychological and behavioral impairment in children with posterior cranial fossa astrocytomas and medulloblastomas: the role of the tumor and the impact of the surgical treatment. Childs Nerv Syst (2010) 1.13
Consensus paper: Language and the cerebellum: an ongoing enigma. Cerebellum (2014) 1.07
Cognitive functions in patients with MR-defined chronic focal cerebellar lesions. J Neurol (2007) 1.00
The contribution of the cerebellum to cognition in Spinocerebellar Ataxia Type 6. Behav Neurol (2010) 0.87
Reduced phonological similarity effects in patients with damage to the cerebellum. Brain Lang (2005) 0.87
Distinct critical cerebellar subregions for components of verbal working memory. Neuropsychologia (2011) 0.85
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms. J Neurol (2012) 0.82
The enigmatic linguistic cerebellum: clinical relevance and unanswered questions on nonmotor speech and language deficits in cerebellar disorders. Cerebellum Ataxias (2014) 0.77
Cerebellar tDCS: A Novel Approach to Augment Language Treatment Post-stroke. Front Hum Neurosci (2017) 0.75
High-angular resolution diffusion imaging tractography of cerebellar pathways from newborns to young adults. Brain Behav (2016) 0.75
Long-term depression in Purkinje neurons is persistently impaired following cardiac arrest and cardiopulmonary resuscitation in mice. J Cereb Blood Flow Metab (2016) 0.75
Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science (1999) 5.20
Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet (2001) 3.09
In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol (1991) 2.70
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in Duchenne muscular dystrophy. Eur Respir J (2009) 1.65
Remarkable infidelity of polymerase gammaA associated with mutations in POLG1 exonuclease domain. Neurology (2003) 1.65
Retrospective diagnosis of congenital cytomegalovirus infection and cortical maldevelopment. Neurology (2003) 1.56
Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol (1999) 1.47
Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet (2001) 1.46
A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Neurology (2003) 1.41
Immunocytochemistry of muscle cytoskeletal proteins in acid maltase deficiency. Muscle Nerve (1994) 1.39
Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol (1998) 1.37
Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet (1990) 1.36
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology (2006) 1.36
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology (2004) 1.33
Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat (2008) 1.33
Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am J Hum Genet (1991) 1.31
Stem cell therapy in stroke. Cell Mol Life Sci (2009) 1.27
Unusual cognitive and behavioural profile in a Williams syndrome patient with atypical 7q11.23 deletion. J Med Genet (2003) 1.26
Fatal infantile cytochrome c oxidase deficiency: decrease of immunologically detectable enzyme in muscle. Neurology (1985) 1.25
Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology (2004) 1.22
Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis. Ann Neurol (2001) 1.21
Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet (2008) 1.20
Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet (1994) 1.19
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol (2009) 1.18
Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther (2001) 1.17
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant (2007) 1.16
Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet (2011) 1.14
Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol (2000) 1.13
Clinical findings in 56 cows with toxic mastitis. Vet Rec (2006) 1.10
Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates. Brain (1994) 1.10
Leber's hereditary optic neuropathy: genetic, biochemical, and phosphorus magnetic resonance spectroscopy study in an Italian family. Neurology (1991) 1.09
A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet (2004) 1.07
Peripheral neuropathy in mitochondrial disease. J Neurol Sci (1987) 1.05
Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. J Biol Chem (1996) 1.05
Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. Exp Cell Res (2001) 1.04
The dystrophin gene is alternatively spliced throughout its coding sequence. FEBS Lett (2002) 1.04
Novel exon 1 progranulin gene variant in Alzheimer's disease. Eur J Neurol (2008) 1.03
Cytochrome c oxidase deficiency. Biochem Soc Trans (1985) 1.02
Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2006) 1.02
Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology (1998) 1.02
Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clin Genet (2011) 1.02
Lack of apoptosis in mitochondrial encephalomyopathies. Neurology (2001) 1.01
Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues. Ann Neurol (1987) 1.01
Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol Life Sci (2010) 1.01
Effects of gender and posture on thoraco-abdominal kinematics during quiet breathing in healthy adults. Respir Physiol Neurobiol (2010) 1.00
A prospective survey of febrile events in hematological malignancies. Ann Hematol (2011) 0.99
Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy. Clin Genet (2010) 0.98
Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology (2000) 0.98
Body building and myoglobinuria: report of three cases. Br Med J (Clin Res Ed) (1988) 0.97
Characteristics of shiga toxin-producing Escherichia coli isolated from Swiss raw milk cheese within a 3-year monitoring program. J Food Prot (2010) 0.97
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res (1985) 0.96
Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology (2008) 0.96
Microbiological quality of raw goat's and ewe's bulk-tank milk in Switzerland. J Dairy Sci (2003) 0.96
Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum. J Med Genet (2009) 0.96
Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells. Cell Transplant (2003) 0.95
Respiratory pattern in an adult population of dystrophic patients. J Neurol Sci (2011) 0.95
Prevalence and characteristics of Shiga toxin-producing Escherichia coli in Swiss raw milk cheeses collected at producer level. J Dairy Sci (2008) 0.94
Inverted duplications are recurrent rearrangements always associated with a distal deletion: description of a new case involving 2q. Eur J Hum Genet (2000) 0.94
Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms. Hum Genet (2001) 0.94
Growth factors in ischemic stroke. J Cell Mol Med (2009) 0.94
Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromuscul Disord (2000) 0.94
Academic performance in children with rolandic epilepsy. Dev Med Child Neurol (2008) 0.93
Long-term balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene. Hum Genet (2010) 0.93
Neuroectodermal and microglial differentiation of bone marrow cells in the mouse spinal cord and sensory ganglia. J Neurosci Res (2002) 0.93
Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases. J Neurol (1994) 0.93
Acute diazepam administration produces rapid increases in brain benzodiazepine receptor density. Eur J Pharmacol (1979) 0.92
CD34-positive cells: biology and clinical relevance. Haematologica (1995) 0.92
A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse. Exp Cell Res (2002) 0.92
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation. Leukemia (2003) 0.92
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2011) 0.92
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components. Cancer Chemother Pharmacol (2001) 0.92
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration. Eur J Neurol (2009) 0.92
The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. J Neurol Sci (1997) 0.92
Trans-acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles. FEBS Lett (2003) 0.92
Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections. Clin Microbiol Infect (2012) 0.91
The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K. J Med Genet (2010) 0.91
High-resolution X-ray microtomography for three-dimensional visualization of human stem cell muscle homing. FEBS Lett (2006) 0.90
Phenotypic and genotypic characteristics of Staphylococcus aureus isolates from raw bulk-tank milk samples of goats and sheep. Vet Microbiol (2004) 0.90
Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL. Hum Mutat (2006) 0.90
Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation. Ann Neurol (1980) 0.90
Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation. J Neurol (2001) 0.90
Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection. Glia (2007) 0.89
Novel donor splice site mutations of AGL gene in glycogen storage disease type IIIa. J Inherit Metab Dis (1999) 0.89
Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL. Hum Mutat (2002) 0.89
Carnitine palmityl transferase deficiency: clinical variability, carrier detection, and autosomal-recessive inheritance. Neurology (1981) 0.89
Atypical adult onset complicated spastic paraparesis with thin corpus callosum in two patients carrying a novel FA2H mutation. Eur J Neurol (2012) 0.89
Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area. Am J Med Genet (2002) 0.88
Glucose-6-phosphate dehydrogenase Lodi844C: a study on its expression in blood cells and muscle. Enzyme (1991) 0.88
Molecular analysis of LGMD-2B and MM patients: identification of novel DYSF mutations and possible founder effect in the Italian population. Neuromuscul Disord (2003) 0.87
Neuronal differentiation of murine bone marrow Thy-1- and Sca-1-positive cells. J Hematother Stem Cell Res (2003) 0.87
A G+1-->A transversion at the 5' splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient. Hum Mol Genet (1995) 0.87
Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica (1999) 0.87